Caffeine/Propranolol Intervention for Acute Migraine
NCT01080677
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Migraine Disorders
Interventions
DRUG:
caffeine/propranolol combination tablet
DRUG:
placebo
Sponsor
Stanford University